Showing posts with label cardiac. Show all posts
Showing posts with label cardiac. Show all posts
Monday, September 06, 2010
abstract: Monitoring long-term treatment with pegylated liposomal doxorubicin: how important is intensive cardiac follow-up?
"PLD is cardiac safe for long-term treatment of metastatic solid tumors. Its maximal cumulative dose remains undefined. "
add your opinions
cardiac
,
dose
,
doxil
,
heart
,
longterm followup
,
pegylated liposomal doxorubicin
,
safety
Subscribe to:
Posts
(
Atom
)